Staff cuts sweep across FDA; Tariff rollout raises questions; The R&D 15 is back; and more

Welcome back to Endpoints Weekly! Much of this week’s headlines dealt with the fallout of cuts at the FDA and across HHS, notably including the ouster of CBER chief Peter Marks. Marks said he was ...